NeuralCipher Research overview
The text below is the source article’s original abstract under a verified reuse license. cc by
Parkinson's disease (PD) is a neurodegenerative disorder associated with dopaminergic neuronal loss, mitochondrial dysfunction, and redox imbalance. Huperzine B (HupB), an alkaloid derived from Huperzia species, has demonstrated antioxidant and acetylcholinesterase-inhibitory activity; however, its effects in toxin-induced cellular models of mitochondrial oxidative injury remain incompletely characterized. This study investigated the effects of HupB and an extract derived from Huperzia carinata (E1) in 1-methyl-4-phenylpyridinium (MPP+)-induced SH-SY5Y cells. LC-MS/MS analysis identified Huperzines A, B, and caffeic acid in E1. Cells were pretreated with HupB or E1 prior to exposure to 1 mM MPP+. Cell viability, nuclear morphology, reactive oxygen species (ROS), antioxidant enzyme activity, mitochondrial membrane potential (JC-1), apoptosis-related proteins (Bax/Bcl-2), and global proteomic profiles were evaluated. HupB and E1 attenuated MPP+-induced reductions in cell viability and ROS elevation, while partially improving glutathione levels and catalase and superoxide dismutase activities. MPP+ significantly decreased mitochondrial membrane potential, whereas pretreatments did not produce significant restoration. Similarly, Bax/Bcl-2 expression showed no significant modulation despite trends toward normalization at higher concentrations. Proteomic analysis revealed altered expression of proteins associated with negative regulation of apoptosis and cellular stress responses. These findings indicate that HupB and H. carinata extract are associated with modulation of oxidative and proteostasis-related responses in an MPP+-induced undifferentiated SH-SY5Y cellular injury model, supporting further investigation in more physiologically relevant systems.
Scientific assessment
Research question
Assess the question within the original study’s scope.
Methods & sample
Check the source article for study design and sample details.
Key findings
An editorially approved findings summary is not yet published for this record.
Limitations
Generalizability, bias and clinical meaning require separate assessment.
Methods, samples and clinical conclusions are not inferred from bibliographic metadata.